- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Cannabinoids in the Treatment of Parkinson’s Disease ; volume:01 ; number:04 ; year:2017 ; pages:E307-E311
Neurology international open ; 01, Heft 04 (2017), E307-E311
- Beteiligte Personen und Organisationen
- DOI
-
10.1055/s-0043-115359
- URN
-
urn:nbn:de:101:1-2019070510130186128076
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gandor, Florin
- Ebersbach, Georg
Ähnliche Objekte (12)
Pharmacological treatment of Parkinson’s disease
The treatment of advanced Parkinson's disease
Adenosine A2A receptors in Parkinson’s disease treatment
Off-time Treatment Options for Parkinson’s Disease
Treatment Options for Urogenital Dysfunction in Parkinson’s Disease
Frankincense: A neuronutrient to approach Parkinson’s disease treatment
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
Hypoxia treatment of Parkinson’s disease may disrupt the circadian system
How to optimize the treatment of early stage Parkinson’s disease
Drugs for the treatment of Parkinson's disease
Pharmacological treatment of Parkinson’s disease
The treatment of advanced Parkinson's disease
Adenosine A2A receptors in Parkinson’s disease treatment
Off-time Treatment Options for Parkinson’s Disease
Treatment Options for Urogenital Dysfunction in Parkinson’s Disease
Frankincense: A neuronutrient to approach Parkinson’s disease treatment
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
Hypoxia treatment of Parkinson’s disease may disrupt the circadian system
How to optimize the treatment of early stage Parkinson’s disease
Drugs for the treatment of Parkinson's disease
Pharmacological treatment of Parkinson’s disease
The treatment of advanced Parkinson's disease
Adenosine A2A receptors in Parkinson’s disease treatment
Off-time Treatment Options for Parkinson’s Disease
Treatment Options for Urogenital Dysfunction in Parkinson’s Disease
Frankincense: A neuronutrient to approach Parkinson’s disease treatment
The heterogeneity of Parkinson’s disease
The immunology of Parkinson’s disease
Benefits of Iron Chelators in the Treatment of Parkinson’s Disease
Hypoxia treatment of Parkinson’s disease may disrupt the circadian system
How to optimize the treatment of early stage Parkinson’s disease